| Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure. | |
| | |
MedLine Citation:
|
PMID: 21645517 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The exogenous administration of tetrahydrobiopterin (BH4), an essential cofactor of nitric oxide synthase (NOS), has been shown to reduce left ventricular hypertrophy, fibrosis, and cardiac dysfunction in mice with pre-established heart disease induced by pressure-overload. In this setting, BH4 re-coupled endothelial NOS (eNOS), with subsequent reduction of NOS-dependent oxidative stress and reversal of maladaptive remodeling. However, recent studies suggest the effective BH4 dosing may be narrower than previously thought, potentially due to its oxidation upon oral consumption. Accordingly, we assessed the dose response of daily oral synthetic sapropterin dihydrochloride (6-R-l-erythro-5,6,7,8-tetrahydrobiopterin, 6R-BH4) on pre-established pressure-overload cardiac disease. Mice (n=64) were administered 0-400mg/kg/d BH4 by ingesting small pre-made pellets (consumed over 15-30 min). In a dose range of 36-200mg/kg/d, 6R-BH4 suppressed cardiac chamber remodeling, hypertrophy, fibrosis, and oxidative stress with pressure-overload. However, at both lower and higher doses, BH4 had less or no ameliorative effects. The effective doses correlated with a higher myocardial BH4/BH2 ratio. However, BH2 rose linearly with dose, and at the 400mg/kg/d, this lowered the BH4/BH2 ratio back toward control. These results expose a potential limitation for the clinical use of BH4, as variability of cellular redox and perhaps heart disease could produce a variable therapeutic window among individuals. This article is part of a special issue entitled ''Key Signaling Molecules in Hypertrophy and Heart Failure.'' |
| | |
Authors:
|
An L Moens; Elizabeth A Ketner; Eiki Takimoto; Tim S Schmidt; Charles A O'Neill; Michael S Wolin; Nicholas J Alp; Keith M Channon; David A Kass |
Related Documents
:
|
7707157 - Relationship between blood pressure and renal function. 21686167 - Effect of combined high pressure and thermal treatment on myofibrillar proteins solubil... 11422757 - The natural history of renal disease in australian aborigines. part 1. changes in album... 2517327 - Seizures in haemodialysis patients treated with recombinant human erythropoietin. 3836027 - Naloxone potentiates the cardiovascular effects of catecholamines in canine hemorrhagic... 2913757 - How should we treat a hypertensive emergency? |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2011-05-30 |
Journal Detail:
|
Title: Journal of molecular and cellular cardiology Volume: 51 ISSN: 1095-8584 ISO Abbreviation: J. Mol. Cell. Cardiol. Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-09-19 Completed Date: 2012-01-06 Revised Date: 2013-05-24 |
Medline Journal Info:
|
Nlm Unique ID: 0262322 Medline TA: J Mol Cell Cardiol Country: England |
Other Details:
|
Languages: eng Pagination: 564-9 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Analysis of Variance Animals Biopterin / analogs & derivatives*, metabolism, pharmacokinetics, therapeutic use Cardiotonic Agents / pharmacokinetics, therapeutic use* Dose-Response Relationship, Drug Heart Failure / drug therapy*, etiology, physiopathology Humans Hypertrophy, Left Ventricular / drug therapy*, etiology, physiopathology Ligation Mice Mice, Inbred C57BL Myocardium / pathology Random Allocation Superoxides / metabolism Ventricular Function, Left Ventricular Remodeling / drug effects* |
| Grant Support | |
ID/Acronym/Agency:
|
HL-59480/HL/NHLBI NIH HHS; HL-89297/HL/NHLBI NIH HHS; P50 HL084946-03/HL/NHLBI NIH HHS; R01 HL089297-02/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Cardiotonic Agents; 11062-77-4/Superoxides; 17528-72-2/5,6,7,8-tetrahydrobiopterin; 22150-76-1/Biopterin; 6779-87-9/7,8-dihydrobiopterin |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sociosexuality moderates the association between testosterone and relationship status in men and wom...
Next Document: Dynamic modulation of Ca2+ sparks by mitochondrial oscillations in isolated guinea pig cardiomyocyte...